Jennison Associates LLC Madrigal Pharmaceuticals, Inc. Transaction History

Jennison Associates LLC

$162 Billion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	SELL	$231.06 - $307.08 $6 Million - $7.97 Million	-25,969 Reduced 44.05%	32,987 $7.99 Million
Q4 2022 Feb 09, 2023	SELL	$58.39 - $296.54 $3.18 Million - $16.2 Million	-54,544 Reduced 48.06%	58,956 $17.1 Million
Q3 2022 Nov 01, 2022	SELL	$60.57 - $79.51 $4.18 Million - $5.48 Million	-68,946 Reduced 37.79%	113,500 $7.38 Million
Q2 2022 Aug 02, 2022	BUY	$58.04 - $100.2 $10.6 Million - $18.3 Million	182,446 New	182,446 $13.1 Million
Q3 2020 Nov 04, 2020	SELL	$99.78 - $124.21 $17.7 Million - $22.1 Million	-177,565 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$60.13 - $125.71 $2.85 Million - $5.95 Million	-47,369 Reduced 21.06%	177,565 $20.1 Million
Q1 2020 May 06, 2020	SELL	$66.76 - $93.49 $3.44 Million - $4.81 Million	-51,496 Reduced 18.63%	224,934 $15 Million
Q4 2019 Feb 07, 2020	BUY	$84.28 - $118.5 $62,451 - $87,808	741 Added 0.27%	276,430 $25.2 Million
Q3 2019 Nov 08, 2019	SELL	$84.4 - $106.53 $2.46 Million - $3.11 Million	-29,204 Reduced 9.58%	275,689 $23.8 Million
Q2 2019 Aug 06, 2019	SELL	$91.13 - $142.5 $558,353 - $873,097	-6,127 Reduced 1.97%	304,893 $0
Q1 2019 May 10, 2019	BUY	$103.48 - $143.84 $3.1 Million - $4.31 Million	29,949 Added 10.66%	311,020 $39 Million
Q4 2018 Feb 06, 2019	BUY	$94.77 - $215.54 $5.47 Million - $12.4 Million	57,700 Added 25.83%	281,071 $31.7 Million
Q3 2018 Nov 08, 2018	BUY	$207.3 - $300.31 $12.8 Million - $18.5 Million	61,586 Added 38.07%	223,371 $47.8 Million
Q2 2018 Aug 02, 2018	SELL	$101.55 - $313.9 $6.79 Million - $21 Million	-66,873 Reduced 29.25%	161,785 $45.3 Million
Q1 2018 Apr 20, 2018	BUY	$93.35 - $149.04 $2.28 Million - $3.65 Million	24,458 Added 11.98%	228,658 $26.7 Million
Q4 2017 Jan 25, 2018	BUY	$39.35 - $97.37 $8.04 Million - $19.9 Million	204,200	204,200 $18.7 Million

Others Institutions Holding MDGL

# of Institutions

338

Shares Held

22.7M

Call Options Held

757K

Put Options Held

960K

Janus Henderson Group PLC London, X0

2.21M
Shares

$745 Million
0.36% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$689 Million
38.14% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$684 Million
9.12% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$672 Million
10.03% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$666 Million
6.75% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.77B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account